Stay updated with breaking news from Stuart Peters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frazier Life Sciences Management L.P. boosted its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,401,704 shares of the biopharmaceutical company’s stock after purchasing an additional […]
Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […]
Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]
B. Riley initiated coverage on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research note published on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $25.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on MGNX. TD Cowen raised shares of […]
JMP Securities restated their market outperform rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report report published on Thursday, Benzinga reports. A number of other research firms have also recently commented on MGNX. BTIG Research boosted their price target on shares of MacroGenics from $12.00 to $24.00 and gave the stock […]